DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

202 hedge funds and large institutions have $2.22B invested in Dicerna Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 62 increasing their positions, 64 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
202
Holders Change
+19
Holders Change %
+10.38%
% of All Funds
3.53%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
44
Increased
62
Reduced
64
Closed
25
Calls
$10.7M
Puts
$8.22M
Net Calls
+$2.52M
Net Calls Change
+$5.74M

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$21.3M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
$17M
3
NAMA
Nikko Asset Management Americas
New York
$16.9M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$53.4M
5
AIM
ARK Investment Management
Florida
$12.3M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
$123M
2
CS
Candriam SCA
Luxembourg
$15.6M
3
WP
Woodline Partners
California
$37.3M
4
Goldman Sachs
Goldman Sachs
New York
$22.8M
5
State Street
State Street
Massachusetts
$96.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
Charles Schwab
26
Charles Schwab
California
$18.7M -$1.51M -40,446 -7%
EA
27
Emerald Advisers
Pennsylvania
$18.5M -$1.09M -29,294 -6%
Nuveen Asset Management
28
Nuveen Asset Management
Illinois
$17.4M +$5.07M +135,843 +41%
EMFAT
29
Emerald Mutual Fund Advisers Trust
Pennsylvania
$17.2M -$90K -2,412 -0.5%
Sumitomo Mitsui Trust Group
30
Sumitomo Mitsui Trust Group
Japan
$17M +$17M +456,497 New
NAMA
31
Nikko Asset Management Americas
New York
$16.9M +$16.9M +452,167 New
CS
32
Candriam SCA
Luxembourg
$15.6M -$37M -990,748 -70%
Jennison Associates
33
Jennison Associates
New York
$15.4M – – –
Federated Hermes
34
Federated Hermes
Pennsylvania
$14.7M +$6.82M +182,823 +86%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$12.9M -$254K -6,800 -2%
UBS AM
36
UBS AM
Illinois
$12.7M -$67.5K -1,809 -0.5%
Millennium Management
37
Millennium Management
New York
$12.5M -$3.3M -88,403 -21%
Citadel Advisors
38
Citadel Advisors
Florida
$12.4M -$5.78M -154,975 -32%
PAI
39
Palo Alto Investors
California
$12.4M – – –
AIM
40
ARK Investment Management
Florida
$12.3M +$12.3M +328,441 New
Bank of New York Mellon
41
Bank of New York Mellon
New York
$11.5M +$1.65M +44,329 +17%
PHP
42
Parkman Healthcare Partners
Connecticut
$11.4M +$52.9K +1,418 +0.5%
Two Sigma Investments
43
Two Sigma Investments
New York
$10.5M +$10.5M +280,756 New
Axa
44
Axa
France
$10.4M -$3.51M -93,972 -25%
Bank of America
45
Bank of America
North Carolina
$9.27M +$707K +18,956 +8%
Carson Wealth (CWM LLC)
46
Carson Wealth (CWM LLC)
Nebraska
$8.08M – – –
GIM
47
Granahan Investment Management
Massachusetts
$7.52M +$7.52M +201,512 New
Invesco
48
Invesco
Georgia
$7.09M -$3.76M -100,830 -35%
AllianceBernstein
49
AllianceBernstein
Tennessee
$6.94M +$287K +7,700 +4%
Russell Investments Group
50
Russell Investments Group
United Kingdom
$6.67M +$3.6M +96,476 +117%
1
2
3 4 5